AMGEN INC Performance

031162CS7   70.38  0.34  0.48%   
The bond shows a Beta (market volatility) of -0.3, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning AMGEN are expected to decrease at a much lower rate. During the bear market, AMGEN is likely to outperform the market.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AMGEN INC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, AMGEN is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more
  

AMGEN Relative Risk vs. Return Landscape

If you would invest  7,551  in AMGEN INC on August 26, 2024 and sell it today you would lose (12.00) from holding AMGEN INC or give up 0.16% of portfolio value over 90 days. AMGEN INC is generating 0.0047% of daily returns and assumes 1.2306% volatility on return distribution over the 90 days horizon. Simply put, 10% of bonds are less volatile than AMGEN, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon AMGEN is expected to generate 24.02 times less return on investment than the market. In addition to that, the company is 1.61 times more volatile than its market benchmark. It trades about 0.0 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.15 per unit of volatility.

AMGEN Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for AMGEN's investment risk. Standard deviation is the most common way to measure market volatility of bonds, such as AMGEN INC, and traders can use it to determine the average amount a AMGEN's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0038

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns031162CS7

Estimated Market Risk

 1.23
  actual daily
10
90% of assets are more volatile

Expected Return

 0.0
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 0.0
  actual daily
0
Most of other assets perform better
Based on monthly moving average AMGEN is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AMGEN by adding AMGEN to a well-diversified portfolio.

About AMGEN Performance

By analyzing AMGEN's fundamental ratios, stakeholders can gain valuable insights into AMGEN's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if AMGEN has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if AMGEN has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.